These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
89 related items for PubMed ID: 23600231
21. [Clinicopathological analysis of 80 patients with duodenum gastrointestinal stromal tumors]. Fang Y, Shen K, Xue A, Ling J, Gao X, Shu P, Li H, Hou Y, Qin J, Sun Y, Qin X. Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Jan; 18(1):26-9. PubMed ID: 25656026 [Abstract] [Full Text] [Related]
22. Development and validation of prognostic nomograms for metastatic gastrointestinal stromal tumour treated with imatinib. Lee CK, Goldstein D, Gibbs E, Joensuu H, Zalcberg J, Verweij J, Casali PG, Maki RG, Cioffi A, Mcarthur G, Lord SJ, Yip D, Kanjanapan Y, Rutkowski P. Eur J Cancer; 2015 May; 51(7):852-60. PubMed ID: 25801699 [Abstract] [Full Text] [Related]
26. Long-term follow-up of patients with GIST undergoing metastasectomy in the era of imatinib -- analysis of prognostic factors (EORTC-STBSG collaborative study). Bauer S, Rutkowski P, Hohenberger P, Miceli R, Fumagalli E, Siedlecki JA, Nguyen BP, Kerst M, Fiore M, Nyckowski P, Hoiczyk M, Cats A, Casali PG, Treckmann J, van Coevorden F, Gronchi A. Eur J Surg Oncol; 2014 Apr; 40(4):412-9. PubMed ID: 24491288 [Abstract] [Full Text] [Related]
27. Prognostic analysis of patients with gastrointestinal stromal tumors: a single unit experience with surgical treatment of primary disease. Cao H, Zhang Y, Wang M, Shen DP, Sheng ZY, Ni XZ, Wu ZY, Liu Q, Shen YY, Song YY. Chin Med J (Engl); 2010 Jan 20; 123(2):131-6. PubMed ID: 20137358 [Abstract] [Full Text] [Related]
28. [Clinical pathological features and prognosis analysis of gastrointestinal stromal tumor: a series of 558 cases]. Yang J, Yu J, Ma Z, Kang W, Tian S, Ye X. Zhonghua Wai Ke Za Zhi; 2015 Apr 20; 53(4):274-9. PubMed ID: 26269161 [Abstract] [Full Text] [Related]
29. One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial. Joensuu H, Eriksson M, Sundby Hall K, Hartmann JT, Pink D, Schütte J, Ramadori G, Hohenberger P, Duyster J, Al-Batran SE, Schlemmer M, Bauer S, Wardelmann E, Sarlomo-Rikala M, Nilsson B, Sihto H, Monge OR, Bono P, Kallio R, Vehtari A, Leinonen M, Alvegård T, Reichardt P. JAMA; 2012 Mar 28; 307(12):1265-72. PubMed ID: 22453568 [Abstract] [Full Text] [Related]
31. [Changes of diagnosis and treatment for gastrointestinal stromal tumors during a 18-year period in four medical centers of China]. Qiu H, Zhang P, Feng X, Chen T, Sun X, Yu J, Chen Z, Li Y, Tao K, Li G, Zhou Z. Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov 25; 19(11):1265-1270. PubMed ID: 27928797 [Abstract] [Full Text] [Related]
32. Significance of surgery for prognosis of GIST in cohort from transitional healthcare settings. Zovak M, Boban M, Boban L, Cicek S, Madzar Z, Belev B, Tomas D. Int J Surg; 2014 Nov 25; 12(11):1167-71. PubMed ID: 25091396 [Abstract] [Full Text] [Related]
33. Clinical significance of pathological complete response in patients with metastatic gastrointestinal stromal tumors after imatinib mesylate treatment--lessons learned. Cheng CT, Tsai CY, Yeh CN, Chiang KC, Chen YY, Wang SY, Chen TW, Tseng JH, Jung SM, Chen TC, Yeh TS. Anticancer Res; 2014 Nov 25; 34(11):6617-25. PubMed ID: 25368266 [Abstract] [Full Text] [Related]
34. Radiologic assessment of earliest, best, and plateau response of gastrointestinal stromal tumors to neoadjuvant imatinib prior to successful surgical resection. Tirumani SH, Shinagare AB, Jagannathan JP, Krajewski KM, Ramaiya NH, Raut CP. Eur J Surg Oncol; 2014 Apr 25; 40(4):420-8. PubMed ID: 24238762 [Abstract] [Full Text] [Related]
35. A multicenter long-term study of imatinib treatment for Japanese patients with unresectable or recurrent gastrointestinal stromal tumors. Ogata K, Mochiki E, Ojima H, Haga N, Fukuchi M, Aihara R, Ando H, Uchida N, Toyomasu Y, Suzuki M, Kimura A, Kogure N, Yokobori T, Ohno T, Kuwano H. J Surg Oncol; 2014 Dec 25; 110(8):942-6. PubMed ID: 25164620 [Abstract] [Full Text] [Related]
36. Role of operative therapy in treatment of metastatic gastrointestinal stromal tumors. Zaydfudim V, Okuno SH, Que FG, Nagorney DM, Donohue JH. J Surg Res; 2012 Oct 25; 177(2):248-54. PubMed ID: 22831567 [Abstract] [Full Text] [Related]
37. Preoperative imatinib mesylate (IM) for huge gastrointestinal stromal tumors (GIST). Tang S, Yin Y, Shen C, Chen J, Yin X, Zhang B, Yao Y, Yang J, Chen Z. World J Surg Oncol; 2017 Apr 11; 15(1):79. PubMed ID: 28399894 [Abstract] [Full Text] [Related]
38. New fronts in the adjuvant treatment of GIST. Reichardt P, Joensuu H, Blay JY. Cancer Chemother Pharmacol; 2013 Oct 11; 72(4):715-23. PubMed ID: 23934322 [Abstract] [Full Text] [Related]
39. Follow-up strategies for patients with gastrointestinal stromal tumour treated with or without adjuvant imatinib after surgery. Joensuu H, Martin-Broto J, Nishida T, Reichardt P, Schöffski P, Maki RG. Eur J Cancer; 2015 Aug 11; 51(12):1611-7. PubMed ID: 26022432 [Abstract] [Full Text] [Related]
40. Treatment strategy of rectal gastrointestinal stromal tumor (GIST). Liu H, Yan Z, Liao G, Yin H. J Surg Oncol; 2014 Jun 11; 109(7):708-13. PubMed ID: 24510506 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]